C12N 2710/20022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2710/20022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 519 US grants and 627 published applications in this corpus.
Search patents in C12N- Granted patents
- 519
- Published applications
- 627
- Assignees
- 384
- Inventors
- 1,228
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 8 | 0 |
| 1996 | 5 | 0 |
| 1997 | 25 | 0 |
| 1998 | 21 | 0 |
| 1999 | 25 | 0 |
| 2000 | 18 | 0 |
| 2001 | 22 | 5 |
| 2002 | 25 | 22 |
| 2003 | 18 | 30 |
| 2004 | 12 | 41 |
| 2005 | 16 | 39 |
| 2006 | 12 | 34 |
| 2007 | 27 | 28 |
| 2008 | 24 | 26 |
| 2009 | 16 | 35 |
| 2010 | 18 | 41 |
| 2011 | 12 | 18 |
| 2012 | 15 | 21 |
| 2013 | 11 | 15 |
| 2014 | 19 | 22 |
| 2015 | 19 | 21 |
| 2016 | 18 | 18 |
| 2017 | 19 | 18 |
| 2018 | 18 | 16 |
| 2019 | 12 | 19 |
| 2020 | 9 | 16 |
| 2021 | 12 | 22 |
| 2022 | 11 | 14 |
| 2023 | 10 | 26 |
| 2024 | 11 | 33 |
| 2025 | 14 | 36 |
| 2026 | 6 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Engineered DNA molecule for coding RNA22 Sep 2026US 12,742,172 B2Rinuagene Biotechnology Co., Ltd.
- Cell capable of activating immune system, and pharmaceutical composition containing said cell11 Aug 2026US 12,703,867 B2Riken
- Compositions comprising annexin V and HPV tumor antigen fusion polypeptides and methods for making and use9 Jun 2026US 12,649,767 B2The Johns Hopkins University
- Contraceptive vaccine based on the sperm-associated protein catsper2 Jun 2026US 12,642,843 B2Rensselaer Polytechnic Institute
- Materials and methods relating to immunogenic epitopes from human papilloma virus17 Feb 2026US 12,551,546 B2Arizona Board of Regents on behalf of Arizona State University
- Compositions and methods for peptide-based modulators of human papillomavirus oncoprotein e61 Oct 2026US 2026/0297131 A1Calico Life Sciences LLC
- A therapeutic hpv vaccine based on validated target epitopes20 Aug 2026US 2026/0240974 A1Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Validated hpv16-derived stimulation peptides20 Aug 2026US 2026/0240975 A1Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Methods for Treating HPV16-Associated Cancers20 Aug 2026US 2026/0240979 A1Cue Biopharma, Inc.
- Switchable mrna expression platform6 Aug 2026US 2026/0224679 A1
Most cited
By later US patents
- Amplification of nucleic acid molecules198US 5,169,766 ALife Technologies Corporation · 1992
- Antisense oligonucleotide inhibition of papillomavirus194US 5,457,189 AIsis Pharmaceuticals, Inc. · 1995
- Fusion protein comprising tat-derived transport moiety177US 5,674,980 A1997
- Tat-derived transport polypeptide conjugates165US 5,747,641 A1998
- Nucleic acids encoding and methods of making tat-derived transport polypeptides147US 5,652,122 A1997